FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
1-Year Est. Return
52.94%
1 Year Est. Return
+52.94%
AUM
$2.19B
AUM Growth
-$221M
(-9.2%)
Holding
54
Top Buys
| 1 | +$45.5M | |
| 2 | +$15.5M | |
| 3 | +$15.1M | |
| 4 |
Zai Lab
ZLAB
|
+$12.6M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$10.1M |
Top Sells
| 1 | +$63.1M | |
| 2 | +$33.9M | |
| 3 | +$20.8M | |
| 4 |
Krystal Biotech
KRYS
|
+$18M |
| 5 |
Pliant Therapeutics
PLRX
|
+$14.8M |
Sector Composition
| 1 | Healthcare | 99.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Edgewise Therapeutics
EWTX
$1.58B
| – | – |
-1,271,245
|
|
||
|
52
Pliant Therapeutics
PLRX
$99.4M
| – | – |
-1,120,803
|
|
||
53
Day One Biopharmaceuticals
DAWN
$743M
| – | – |
-689,655
|
|
||
54
Eledon Pharmaceuticals
ELDN
$197M
| – | – |
-1,176,735
|
|